Make scientific figures in minutes
Create publication-quality figures with pre-made icons and templates, all from BioRender's web-based software
Use Icons In The App
Try a synonym, or sign up to request an icon from the app.
Lymphoblast 3
[{"image":"https://icons.cdn.biorender.com/w75xh75/605a14b3c749650026702f10/605a139dc749650026702eac.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a14b3c749650026702f10/605a139dc749650026702eac.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a14b3c749650026702f0f/605a139dc749650026702eac.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a14b3c749650026702f0f/605a139dc749650026702eac.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a14b3c749650026702f0e/605a139dc749650026702eac.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a14b3c749650026702f0e/605a139dc749650026702eac.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a14b3c749650026702f0d/605a139dc749650026702eac.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a14b3c749650026702f0d/605a139dc749650026702eac.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a14b3c749650026702f0c/605a139dc749650026702eac.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a14b3c749650026702f0c/605a139dc749650026702eac.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a14b3c749650026702f0b/605a139dc749650026702eac.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a14b3c749650026702f0b/605a139dc749650026702eac.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a14b3c749650026702f0a/605a139dc749650026702eac.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a14b3c749650026702f0a/605a139dc749650026702eac.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a14b3c749650026702f09/605a139dc749650026702eac.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a14b3c749650026702f09/605a139dc749650026702eac.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a14b3c749650026702f08/605a139dc749650026702eac.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a14b3c749650026702f08/605a139dc749650026702eac.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a14b3c749650026702f07/605a139dc749650026702eac.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a14b3c749650026702f07/605a139dc749650026702eac.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a14b3c749650026702f06/605a139dc749650026702eac.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a14b3c749650026702f06/605a139dc749650026702eac.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a14b3c749650026702f05/605a139dc749650026702eac.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a14b3c749650026702f05/605a139dc749650026702eac.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a14b3c749650026702f04/605a139dc749650026702eac.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a14b3c749650026702f04/605a139dc749650026702eac.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a14b3c749650026702f03/605a139dc749650026702eac.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a14b3c749650026702f03/605a139dc749650026702eac.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a14b3c749650026702f02/605a139dc749650026702eac.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a14b3c749650026702f02/605a139dc749650026702eac.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a14b3c749650026702f01/605a139dc749650026702eac.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a14b3c749650026702f01/605a139dc749650026702eac.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a14b3c749650026702f00/605a139dc749650026702eac.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a14b3c749650026702f00/605a139dc749650026702eac.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a14b3c749650026702eff/605a139dc749650026702eac.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a14b3c749650026702eff/605a139dc749650026702eac.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a14b3c749650026702efe/605a139dc749650026702eac.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a14b3c749650026702efe/605a139dc749650026702eac.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a14b3c749650026702efd/605a139dc749650026702eac.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a14b3c749650026702efd/605a139dc749650026702eac.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a14b3c749650026702efc/605a139dc749650026702eac.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a14b3c749650026702efc/605a139dc749650026702eac.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a14b3c749650026702efb/605a139dc749650026702eac.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a14b3c749650026702efb/605a139dc749650026702eac.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a14b3c749650026702efa/605a139dc749650026702eac.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a14b3c749650026702efa/605a139dc749650026702eac.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a14b3c749650026702ef9/605a139dc749650026702eac.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a14b3c749650026702ef9/605a139dc749650026702eac.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a14b3c749650026702ef8/605a139dc749650026702eac.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a14b3c749650026702ef8/605a139dc749650026702eac.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a14b3c749650026702ef7/605a139dc749650026702eac.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a14b3c749650026702ef7/605a139dc749650026702eac.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a14b3c749650026702ef6/605a139dc749650026702eac.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a14b3c749650026702ef6/605a139dc749650026702eac.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a14b3c749650026702ef5/605a139dc749650026702eac.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a14b3c749650026702ef5/605a139dc749650026702eac.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a14b3c749650026702ef4/605a139dc749650026702eac.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a14b3c749650026702ef4/605a139dc749650026702eac.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a14b3c749650026702ef3/605a139dc749650026702eac.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a14b3c749650026702ef3/605a139dc749650026702eac.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a14b3c749650026702ef2/605a139dc749650026702eac.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a14b3c749650026702ef2/605a139dc749650026702eac.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a14b3c749650026702ef1/605a139dc749650026702eac.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a14b3c749650026702ef1/605a139dc749650026702eac.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a14b3c749650026702ef0/605a139dc749650026702eac.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a14b3c749650026702ef0/605a139dc749650026702eac.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a14b3c749650026702eef/605a139dc749650026702eac.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a14b3c749650026702eef/605a139dc749650026702eac.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a14b3c749650026702eee/605a139dc749650026702eac.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a14b3c749650026702eee/605a139dc749650026702eac.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a14b3c749650026702eed/605a139dc749650026702eac.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a14b3c749650026702eed/605a139dc749650026702eac.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a14b3c749650026702eec/605a139dc749650026702eac.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a14b3c749650026702eec/605a139dc749650026702eac.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a14b3c749650026702eeb/605a139dc749650026702eac.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a14b3c749650026702eeb/605a139dc749650026702eac.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a14b3c749650026702eea/605a139dc749650026702eac.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a14b3c749650026702eea/605a139dc749650026702eac.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a14b3c749650026702ee9/605a139dc749650026702eac.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a14b3c749650026702ee9/605a139dc749650026702eac.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a14b3c749650026702ee8/605a139dc749650026702eac.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a14b3c749650026702ee8/605a139dc749650026702eac.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a14b3c749650026702ee7/605a139dc749650026702eac.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a14b3c749650026702ee7/605a139dc749650026702eac.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a14b3c749650026702ee6/605a139dc749650026702eac.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a14b3c749650026702ee6/605a139dc749650026702eac.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a14b3c749650026702ee5/605a139dc749650026702eac.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a14b3c749650026702ee5/605a139dc749650026702eac.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a14b3c749650026702ee4/605a139dc749650026702eac.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a14b3c749650026702ee4/605a139dc749650026702eac.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a14b3c749650026702ee3/605a139dc749650026702eac.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a14b3c749650026702ee3/605a139dc749650026702eac.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a14b3c749650026702ee2/605a139dc749650026702eac.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a14b3c749650026702ee2/605a139dc749650026702eac.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a14b3c749650026702ee1/605a139dc749650026702eac.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a14b3c749650026702ee1/605a139dc749650026702eac.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a14b3c749650026702ee0/605a139dc749650026702eac.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a14b3c749650026702ee0/605a139dc749650026702eac.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a14b3c749650026702edf/605a139dc749650026702eac.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a14b3c749650026702edf/605a139dc749650026702eac.png"}]
Use this icon in BioRender along with 1000s of others to make your next science figure in minutes
.png)
SIGN UP FREEKeywords
lymphoblast,leukemic blast,blast,naive lymphocyte,naive,lymphocyte,agnostic leukemia blast cells,myeloblastic leukemia,leukemia,leukaemia,immature,activated,stimulated,big nucleus,large nucleus,acute lymphoblastic leukemia,ALL,peripheral blood,bone marrow,lymphoblast
Image types
BioRender icons and templates meet journal, grant, and copyright standards. For AI-generated figures, policies vary. Learn More
Related Categories
Join 1,500,000 other scientists on BioRender
Sign up for your free account and start creating scientific figures faster today
FAQs
What is BioRender?
Can I use this icon in a BioRender figure or scientific illustration?
